Log in
Enquire now
Simbiosys

Simbiosys

Simbiosys is a toronto-based chemistry software company founded in 2018.

OverviewStructured DataIssuesContributors
Is a
Company
Company
Organization
Organization
B2X
B2B
B2B
0
Legal Name
SimBioSys, Inc.
0
Company Operating Status
Active
Country
United States
United States
Crunchbase URL
crunchbase.com/organiz...sys-4a78
Email Address
media@simbiosys.com
0
partner@simbiosys.com
0
contact@simbiosys.com
0
Founded Date
2018
Full Address
60 Hazelwood Drive, Suite 230D, Champaign, IL 68120
0
180 North LaSalle Street, Suite 3250, Chicago, Illinois 60601, US
0
Headquarters
Toronto
Toronto
Industry
Software
Software
Cancer
Cancer
Oncology
Oncology
Engineering
Engineering
Internal medicine
Internal medicine
Healthcare
Healthcare
Medicine
Medicine
Technology
Technology
Biomedical engineering
Biomedical engineering
Diagnosis
Diagnosis
Investors
Heritage Group
Heritage Group
Genoa Ventures
Genoa Ventures
AV8 Ventures
AV8 Ventures
Northpond Ventures
Northpond Ventures
Latest Funding Round Date
October 27, 2021
Latest Funding Round Amount (USD)
15,000,000
Latest Funding Type
Series A
Series A
LinkedIn URL
@company/simbiosys-inc
Location
Champaign, Illinois
Champaign, Illinois
0
Chicago
Chicago
0
Number of Employees (Ranges)
11 – 50
0
Pitchbook URL
pitchbook.com/profiles...234683-83
Total Funding Amount (USD)
15,000,000
Twitter URL
@simbiosys
Official Website
simbiosys.com
Wikidata ID
Q7517437

Find more companies like Simbiosys

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.